Hypertension. Hypertensive diseases
Conditions
Interventions
Intervention 1: In group B patients are tested under Remifentanil infusion at a rate of 0.1 -0.3 mcg / kg / min . Intervention 2: Group A, besides induction of anesthesia , received 1mg Inderal and 20
Treatment - Drugs
In group B patients are tested under Remifentanil infusion at a rate of 0.1 -0.3 mcg / kg / min .
Group A, besides induction of anesthesia , received 1mg Inderal and 20mg Hydralazine.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criterion: all patients in the range of 20-40 years old with class I ASA. Exclusion criteria: patients in class II & III ASA; recent (the last 3 months) general anesthesia record; drug abuse; history of allergy to Propranolol or Hydralazine or Remifentanil; high blood pressure; cardiovascular diseases should be eliminated.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Before intervention, during intervention, after intervention. Method of measurement: In terms of mmHg, using a Mercury sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bleeding during surgery. Timepoint: After intervention. Method of measurement: According to surgeon report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Seyyed Ebrahim Sadeghi
Shiraz University of Medical Sciences
Outcome results
None listed